Comparative lung distribution of radiolabeled tobramycin between nebulized and intravenous administration in a mechanically-ventilated ovine model, an observational study.

Int J Antimicrob Agents

UQ Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, Australia; Department of Intensive Care Medicine, Royal Brisbane & Women's Hospital, Brisbane, Australia; Centre for Translational Anti-infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, Australia; Department of Pharmacy, Royal Brisbane & Women's Hospital, Brisbane, Australia.

Published: February 2021

Background: Ventilator-associated pneumonia is common and is treated using nebulized antibiotics. Although adequate pulmonary biodistribution is important for antibiotic effect, there is a lack of data for both intravenous (IV) and nebulized antibiotic administration during mechanical ventilation.

Objective: To describe the comparative pulmonary regional distribution of IV and nebulized technetium-99m-labeled tobramycin (Tc-tobramycin) 400 mg in a mechanically-ventilated ovine model.

Methods: The study was performed in a mechanically-ventilated ovine model. Tc-tobramycin 400 mg was obtained using a radiolabeling process. Computed tomography (CT) was performed. Ten sheep were given Tc-tobramycin 400 mg via either an IV (five sheep) or nebulized (five sheep) route. Planar images (dorsal, ventral, left lateral and right lateral) were obtained using a gamma camera. Blood samples were obtained every 15 min for 1 h (4 time points) and lung, liver, both kidney, and urine samples were obtained post-mortem.

Results: Ten sheep were anesthetized and mechanically ventilated. Whole-lung deposition of nebulized Tc-tobramycin 400 mg was significantly lower than with IV (8.8% vs. 57.1%, P<0.001). For both administration routes, there was significantly lower deposition in upper lung zones compared with the rest of the lungs. Dorsal deposition was significantly higher with nebulized Tc-tobramycin 400 mg compared with IV (68.9% vs. 58.9%, P=0.003). Lung concentrations of Tc-tobramycin were higher with IV compared with nebulized administration. There were significantly higher concentrations of Tc-tobramycin in blood, liver and urine with IV administration compared with nebulized.

Conclusions: Nebulization resulted in lower whole and regional lung deposition of Tc-tobramycin compared with IV administration and appeared to be associated with low blood and extra-pulmonary organ concentrations.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijantimicag.2020.106232DOI Listing

Publication Analysis

Top Keywords

mechanically-ventilated ovine
12
tc-tobramycin 400
12
ovine model
8
ten sheep
8
nebulized
6
comparative lung
4
lung distribution
4
distribution radiolabeled
4
radiolabeled tobramycin
4
tobramycin nebulized
4

Similar Publications

An ovine septic shock model of live bacterial infusion.

Intensive Care Med Exp

October 2024

Critical Care Research Group, The Prince Charles Hospital, 627 Rode Road, Level 3 Clinical Sciences Building, Chermside, Brisbane, QLD, 4032, Australia.

Article Synopsis
  • Escherichia coli is a leading cause of bloodstream infections and sepsis, but existing animal models fail to replicate the complexities of these conditions, hindering the development of effective treatments.
  • Researchers aimed to create a more accurate large-animal model of septic shock using sheep, by infusing a specific strain of antibiotic-resistant E. coli and closely monitoring their health over 48 hours.
  • The study successfully induced septic shock in five sheep, showing consistent and reproducible results, including significant drops in blood pressure and increases in lactate levels following the bacterial infusion.
View Article and Find Full Text PDF

Hyperpolarized 129Xe Lung MRI and Spectroscopy in Mechanically Ventilated Mice.

J Vis Exp

October 2024

Center for Pulmonary Imaging Research, Division of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center; Department of Biomedical Engineering, University of Cincinnati; Imaging Research Center, Department of Radiology, Cincinnati Children's Hospital Medical Center; Department of Pediatrics, University of Cincinnati; Division of Pulmonary Medicine, Cincinnati Children's Hospital Medical Center;

Article Synopsis
  • Hyperpolarized xenon-129 (Xe) is a specialized MRI contrast agent that helps measure various aspects of lung function, making it useful for diagnosing and tracking lung diseases in humans.
  • It is approved for clinical use in places like the U.S. and U.K. and offers noninvasive ways to study lung health in preclinical research settings, particularly with mice, which are commonly used in genetic studies.
  • The text outlines practical procedures and checklists for effectively using Xe MRI in animal studies, focusing on ensuring accurate data collection related to lung disease monitoring.
View Article and Find Full Text PDF

Background: In mechanically ventilated neonates, the arterial partial pressure of ( ) is an important indicator for the adequacy of ventilation settings. Determining the is commonly done using invasive blood gas analyses, which constitute risks for neonates and are typically only available infrequently. An accurate, reliable, and continuous estimation of is of high interest for medical staff, giving the possibility of a closer monitoring and faster reactions to changes.

View Article and Find Full Text PDF
Article Synopsis
  • Mucus plugging in respiratory diseases like asthma and cystic fibrosis can block airways, causing serious breathing issues.
  • A study tested a combination treatment called BromAc on mucus plugs in a lung model using sheep to see its effectiveness.
  • Results showed that BromAc significantly reduced airway resistance and viscosity of mucus compared to saline, leading to better airflow and suggesting it worked better than individual treatments.
View Article and Find Full Text PDF

Hemorrhagic shock is a major source of morbidity and mortality worldwide. While whole blood or blood product transfusion is a first-line treatment, maintaining robust supplies presents significant logistical challenges, particularly in austere environments. OMX is a novel nonhemoglobin (Hb)-based oxygen carrier derived from the H-NOX (heme-nitric oxide/oxygen binding) protein family.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!